Recent MBOT News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/19/2024 11:46:05 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/19/2024 11:43:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/19/2024 11:40:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 12:30:37 PM
- Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center • GlobeNewswire Inc. • 07/18/2024 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/09/2024 09:28:43 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/09/2024 09:28:41 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/09/2024 09:26:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 12:30:19 PM
- Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial • GlobeNewswire Inc. • 07/09/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 12:20:41 PM
- Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial • GlobeNewswire Inc. • 07/08/2024 12:20:00 PM
- Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial • GlobeNewswire Inc. • 07/03/2024 12:20:00 PM
- Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial • GlobeNewswire Inc. • 06/20/2024 12:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 12:30:20 PM
- Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial • GlobeNewswire Inc. • 06/17/2024 12:30:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 06/11/2024 05:15:27 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/11/2024 05:14:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 08:35:13 PM
- Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules • GlobeNewswire Inc. • 06/04/2024 08:20:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/04/2024 12:30:21 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 06/03/2024 08:01:46 PM
- Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules • GlobeNewswire Inc. • 06/03/2024 04:11:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 12:20:23 PM
- Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial • GlobeNewswire Inc. • 06/03/2024 12:20:00 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM